A cross-sectional study on metabolic syndrome and its abnormal components in cancer patients

樊娜,孙绍梅,张卿,高鹰,魏玮
DOI: https://doi.org/10.3760/cma.j.cn112150-20201201-01412
2021-01-01
Abstract:From December 2017 to December 2018, 3 509 subjects who had regular physical examination in Health Management Center, Tianjin Medical University General Hospital were enrolled in our study, including 399 cancer patients, 1 555 chronic disease patients, and 1 555 healthy control, respectively. The mean age was (55.87±11.98) years, and 31.38% were men. The prevalence of MS among chronic disease group (42.44%) was higher than that of cancer group (34.59%) and healthy control group (18.65%) (<0.001). Compared with healthy control group, the (95%) values of MS risk in cancer group and chronic disease group were 2.13 (1.61-2.83) and 2.85 (2.23-3.66), respectively; the (95%) values of MS risk were 3.56 (2.04-6.21) and 2.77 (1.46-5.25) in breast cancer and thyroid cancer, respectively.
What problem does this paper attempt to address?